Share
Daily SumUp
AstraZeneca to invest $2.5 billion in China research and development hub
Biopharmaceutical multinational AstraZeneca is not letting a bumpy 2024 dictate its path forward in China, and in the wake of a recent controversy emerges a multibillion-dollar commitment to China-based research – plus the company’s first vaccine-manufacturing facility in the country.
The British-Swedish drug maker, which saw one of its executives detained in China last year, announced a multibillion-dollar investment deal last week, before its CEO attended a global business forum in Beijing.
AstraZeneca inked a US$2.5 billion contract with the city government of Beijing to establish the firm’s sixth global strategic R&D centre, with high-end industrialisation projects conducted in the Chinese capital to advance life sciences throughout the country.
More episodes
View all episodes
Iran says 18 killed, 108 wounded in Tuesday's US attacks
02:02|Iran says 18 killed, 108 wounded in Tuesday's US attacks...India Eyes Russia’s S-500 Air Defense Missile System Against China as U.S. Ties Deepen.
01:27|India Eyes Russia’s S-500 Air Defense Missile System Against China as U.S. Ties Deepen.,,,,Rich Dad Poor Dad" author Robert Kiyosaki has amassed a staggering $1.2 billion in debt tied to his wide-ranging real estate investments.
02:16|Rich Dad Poor Dad" author Robert Kiyosaki has amassed a staggering $1.2 billion in debt tied to his wide-ranging real estate investments....